16.55MMarket Cap-2.26P/E (TTM)
1.980High1.760Low250.33KVolume1.800Open1.890Pre Close470.75KTurnover4.57%Turnover RatioLossP/E (Static)8.71MShares4.84052wk High4.33P/B10.41MFloat Cap1.43052wk Low--Dividend TTM5.48MShs Float9.500Historical High--Div YieldTTM11.64%Amplitude1.430Historical Low1.880Avg Price1Lot Size
BullFrog AI Stock Forum
Bullfrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial
BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial
1 minute ago, 5:00 AM PST
Via GlobeNewswire
BFRGBFRGW
Share
GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics...
$BULLFROG AI HOLDINGS INC C/WTS EXP (TO PUR COM) (BFRGW.US)$
No comment yet